Neurohormones, Neurodevelopment, and the Prodrome of Psychosis in Adolescence

Adolescent Psychopathology and the Developing Brain: Integrating Brain and Prevention Science

Volumn , Issue , 2007, Pages

  Walker, Elaine F ^a   McMillan, Amanda ^a   Mittal, Vijay ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

HPA function; Hypothalamic pituitary adrenal axis; Psychosis; Stress

Indexed keywords

EID: 84918914866     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195306255.003.0012     Document Type: Chapter

References (96)

1. Altamura, A. C., Boin, F., & Maes, M. (1999). HPA axis and cytokines dysregulation in schizophrenia: Potential implications for the antipsychotic treatment. European Neuropsychopharmacology, 10(1), 1-4.
2. Antonova, E., Sharma, T., Morris, R., & Kumari, V. (2004). The relationship between brain structure and neurocognition in schizophrenia: A selective review. Schizophrenia Research, 70(2-3), 117-145.
3. Arnold, A. P., & Breedlove, S. M. (1985). Organizational and activational effects of sex steroids on brain and behavior: A reanalysis. Hormones and Behavior, 19(4), 469-498.
4. Arnsten, A. F., & Shansky, R. M. (2004). Adolescence: Vulnerable period for stress-induced prefrontal cortical function? Introduction to part IV. Annals of the New York Academy of Sciences, 1021, 143-147.
5. Baare, W. F., van Oel, C. J., Hulshoff Pol, H. E., Schnack, H. G., Durston, S., Sitskoorn, M. M., & Kahn, R. S. (2001). Volumes of brain structures in twins discordant for schizophrenia. Archives of General Psychiatry, 58(1), 33-40.
6. Beach, F. A. (1975). Behavioral endocrinology: An emerging discipline. American Scientist, 63(2), 178-187.
7. Bhagwagar, Z., Hafizi, S., & Cowen, P. J. (2002). Acute citalopram administration produces correlated increases in plasma and salivary cortisol. Psychopharmacology, 163, 118-120.
8. Brown, E. S., Woolston, D., Frol, A., Bobadilla, L., Kahn, D. A., Hanczyc, M., Rush, A. J., Fleckenstein, J., Babcock, E., & Cullum, C. M. (2004). Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biological Psychiatry, 55(5), 538-545.
9. Brown, W. A., & Williams, B. W. (1976). Methylphenidate increases serum growth hormone concentrations. Journal of Clinical Endocrinology and Metabolism, 43, 937-939.
10. Buchanan, C. M., Eccles, J. S., & Becker, J. B. (1992). Are adolescents the victims of raging hormones? Evidence for activational effects of hormones on moods and behavior at adolescence. Psychological Bulletin, 111(1), 62-107.
11. Chambers, R. A., Taylor, J. R., & Potenza, M. N. (2003). Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. American Journal of Psychiatry, 160(6), 1041-1052.
12. Charmandari, E., Kino, T., Souvatzoglou, E., & Chrousos, G. P. (2003). Pediatric stress: Hormonal mediators and human development. Hormone Research, 59(4), 161-179.
13. Coe, C. L., Kramer, M., Czeh, B., Gould, E., Reeves, A. J., Kirschbaum, C., & Fuchs, E. (2003). Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile rhesus monkeys. Biological Psychiatry, 54(10), 1025-1034.
14. Compas, B. E., Connor-Smith, J., & Jaser, S. S. (2004). Temperament, stress reactivity, and coping: Implications for depression in childhood and adolescence. Journal of Clinical Child and Adolescent Psychology, 33(1), 21-31.
15. Cunningham, M. G., Bhattacharyya, S., & Benes, F. M. (2002). Amygdalocortical sprouting continues into early adulthood: Implications for the development of normal and abnormal function during adolescence. Journal of Comparative Neurology, 453(2), 116-130.
16. Curran, C., Byrappa, N., & McBride, A. (2004). Stimulant psychosis: Systemic review. British Journal of Psychiatry, 185, 196-204.
17. Curtis, V. A., Wright, P., Reveley, A., Kerwin, R., & Lucey, J. V. (1995). Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement. British Journal of Psychiatry, 166, 642-646.
18. De Bellis, M. D., Clark, D. B., Beers, S. R., Soloff, P. H., Boring, A. M., Hall, J., Kersch, A. K., & Matcheri, S. (2000). Hippocampal volume in adolescent-onset alcohol use disorders. American Journal of Psychiatry, 157(5), 737-744.
19. de Leon, M. J., McRae, T., Rusinek, H., Convit, A., De Santi, S., Tarshish, C., Golomb, J., Volkow, N., Daisley, K., Orentreich, N., & McEwen, B. (1997). Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. Journal of Clinical Endocrinology and Metabolism, 82(10), 3251-3259.
20. Deuschle, M., Hamann, B., Meichel, C., Krumm, B., Lederbogen, F., Kniest, A., Colla, M., & Heuser, I. (2003). Antidepressive treatment with amitriptyline and paroxetine: Effects on saliva cortisol concentrations. Journal of Clinical Psychopharmacology, 23, 201-205.
21. Dorn, L. D., & Chrousos, G. P. (1997). The neurobiology of stress:Understanding regulation of affect during female biological transitions. Seminars in Reproductive Endocrinology, 15(1), 19-35.
22. Dorn, L. D., Hitt, S. F., & Rotenstein, D. (1999). Biopsychological and cognitive differences in children with premature vs. on-time adrenarche. Archives of Pediatrics and Adolescent Medicine, 153, 137-146.
23. Ferrari, E., Fioravanti, M., Magri, F., & Solerte, S. B. (2000). Variability of interactions between neuroendocrine and immunological functions in physiological aging and dementia of the Alzheimer's type. Annals of the New York Academy of Sciences, 917, 582-596.
24. First, M., Spitzer, R. L., Gibbon, M., & Williams, J. B. (1995). Structured Clinical Interview for the DSM-IV Axis I Disorders (SCID-I), Patient Edition. Washington, DC: American Psychiatric Press.
25. Ganguli, R., Singh, A., Brar, J., Carter, C., & Mintun, M. (2002). Hydrocortisone induced regional cerebral activity changes in schizophrenia: A PET scan study. Schizophrenia Research, 56(3), 241-247.
26. Gogtay, N., Giedd, J. N., Lusk, L., Hayashi, K. M., Greenstein, D., Vaituzis, A. C., Nugent, T. F., III, Herman, D. H., Clasen, L. S., Toga, A. W., Rapoport, J. L., & Thompson, P. M. (2004). Dynamic mapping of human cortical development during childhood through early adulthood. Proceedings of the National Academy of Science of the United States of America, 101(21), 8174-8179.
27. Grady, T. A., Broocks, A., Canter, S. K., Pigott, T. A., Dubbert, B., Hill, J. L., & Murphy, D. L. (1996). Biological and behavioral responses to Damphetamine, alone and in combination with serotonin3 receptor antagonist ondasterone, in healthy volunteers. Psychiatry Research, 64, 1-10.
28. Harmer, C. J., Bhagwagar, Z., Shelley, N., & Cowen, P. J. (2003). Contrasting effects of citalopram and reboxetine on waking salivary cortisol. Psychopharmacology, 167, 112-114.
29. Harrison, P. J. (2004). The hippocampus in schizophrenia: A review of the neuropatho-logical evidence and its pathophysiological implications. Psychopharmacology, 174(1), 151-162.
30. Heuser, I., Deuschle, M., Weber, B., Stalla, G. K., & Holsboer, F. (2000). Increased activity of the hypothalamus-pituitary-adrenal system after treatment with mineralocor-ticoid receptor antagonist spironolactone. Psychoneuroendocrinology, 25(5), 513-518.
31. Hibberd, C., Yau, J. L., & Seckl, J. R. (2000). Glucocorticoids and the ageing hippocampus. Journal of Anatomy, 197(4), 553-562.
32. Inder, W. J., Prickett, T. C. R., Mulder, R. T., Donald, R. A., & Joyce, P. R. (2001). Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology, 156, 73-78.
33. Irwin, C. E., Jr., Burg, S. J., & Uhler Cart, C. (2002). America's adolescents:Where have we been, where are we going? Journal of Adolescent Health. 31(6 Suppl.), 91-121.
34. Isgor, C., Kabbaj, M., Akil, H., & Watson, S. J. (2004). Delayed effects of chronic variable stress during peripubertal-juvenile period on hippocampal morphology and on cognitive and stress axis functions in rats. Hippocampus, 14(5), 636-648.
35. Jang, M., Shin, M., Jung, S., Lee, T., Bahn, G., Kwon, Y. K., Kim, E., & Kim, C. (2002). Alcohol and nicotine reduce cell proliferation and enhance apoptosis in dentate gyrus. Neuroreport: ForRapid Communication of Neuroscience Research, 13(12), 1509-1513.
36. Joyce, P. R., Donald, R. A., Nicholls, M. G., Livesey, J. H., & Abbott, R. M. (1986). Endocrine and behavioral responses to methylphenidate in normal subjects. Biological Psychiatry, 21, 1015-1023.
37. Kawata, M. (1995). Roles of steroid hormones and their receptors in structural organization in the nervous system. Neuroscience Research, 24, 1-46.
38. Keenan, P. A., & Soleymani, R. M. (2001). Gonadal steroids and cognition. In R. E. Tarter, M. Butters, et al. (Eds.), Medical neuropsychology: Clinical issues in neuropsychology (2nd ed., pp. 181-197). Dordrecht, Netherlands: Kluwer Academic.
39. Kenny, F. M., Gancayo, G. P., Heald, F. P., & Hung, W. (1966). Cortisol production rate in adolescent males in different stages of sexual maturation. Journal of Clinical Endocrinology, 26, 1232-1236.
40. Kenny, F. M., Preeyasombat, C., & Migeon, C. J. (1966). Cortisol production rate: II. Normal infants, children and adults. Pediatrics, 37, 34-42.
41. Kiess, W., Meidert, A., Dressendorfer, R. A., Scheiver, K., Kessler, U., & Konig, A. (1995). Salivary cortisol levels throughout childhood and adolescence:Relation with age, pubertal stage and weight. Pediatric Research, 37, 502-506.
42. Kunzel, H. E., Binder, E. B., Nickel, T., Ising, M., Fuchs, B., Majer, M., Pfennig, A., Ernst, G., Kern, N., Schmid, D. A., Uhr, M., Holsboer, F., & Modell, S. (2003). Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology, 28, 2169-2178.
43. Laakmann, G., Hennig, J., Baghai, T., & Schule, C. (2003). Influence of mirtazapine on salivary cortisol in depressed patients. Neuropsychobiology, 47, 31-36.
44. Laakmann, G., Schule, C., Baghai, T., & Waldvogel, E. (1999). Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects. Psycho-neuroendocrinology, 24, 769-784.
45. Lee, P. R., Brady, D., & Koenig, J. I. (2003). Corticosterone alters N-methyl-Daspartate receptor subunit mRNA expression before puberty. Molecular Brain Research, 115(1), 55-62.
46. Luna, B., & Sweeney, J. A. (2004). The emergence of collaborative brain function: FMRI studies of the development of response inhibition. Annals of the New York Academy of Sciences, 1021, 296-309.
47. Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P., Thakur, M., McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998). Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neuroscience, 1(1), 69-73.
48. Lupien, S. J., Wilkinson, C. W., Briere, S., Menard, C., Ng Ying Kin, N. M., & Nair, N. P. (2002). The modulatory effects of corticosteroids on cognition:Studies in young human populations. Psychoneuroendocrinology, 27, 401-416.
49. Markianos, M., Hatzimanolis, J., & Lykouras, L. (1999). Switch from neuroleptics to clozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenic patients. European Neuropsychopharmacology, 9, 533-536.
50. McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T. J., Woods, S. W., Hawkins, K. A., Hoffman, R., Lindborg, S., Tohen, M., & Breier, A. (2003). The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophrenia Research, 61(1), 7-18.
51. McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., Adlard, S., & Jackson, H. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59(10), 921-928.
52. Meaney, M. J., Diorio, J., Francis, D., Widdowson, J., LaPlante, P., Caldji, C., Sharma, S., Seckl, J. R., & Plotsky, P. M. (1996). Early environmental regulation of forebrain glucocorticoid receptor gene expression: Implications for adrenocortical responses to stress. Developmental Neuroscience, 18(1-2), 49-72.
53. Meaney, M. J., O'Donnell, D., Rowe, W., Tannenbaum, B., Steverman, A., Walker, M., Nair, N. P., & Lupien, S. (1995). Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Experimental Gerontology, 30(3-4), 229-251.
54. Mesce, K. A. (2002). Metamodulation of the biogenic amines: second-order modulation by steroid hormones and amine cocktails. Brain, Behavior and Evolution, 60(6), 339-349.
55. Miller, T. J., Zipursky, R. B., Perkins, D., Addington, J., Woods, S. W., Hawkins, K. A., Hoffman, R., Preda, A., Epstein, I., Addington, D., Lindborg, S., Marquez E., Tohen, M., Breier, A., & McGlashan, T. H. (2003). The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophrenia Research, 61(1), 19-30.
56. Muck-Seler D., Pivac, N., Mustapic, M., Crncevic, Z., Jokovljevic, M., & Sagud, M. (2004). Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women. Psychiatry Research, 127(3), 217-226.
57. Muck-Seler, D., Pivac, N., Sagud, M., Jakovljevic, M., & Mihaljevic-Peles, A. (2002). The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Progress in Neuropsychopharmacology and Biological Psychiatry, 26, 1235-1423.
58. Neumann, C., & Walker, E. (1995). Developmental pathways to schizophrenia: Behavioral subtypes. Journal of Abnormal Psychology, 104, 1-9.
59. Ohl, F., Michaelis, T., Vollmann-Honsdorf, G. K., Kirschbaum, C., & Fuchs, E. (2000). Effect of chronic psychosocial stress and long-term cortisol treatment on hippocampus-mediated memory and hippocampal volume: a pilot-study in tree shrews. Psycho-neuroendocrinology, 25(4), 357-363.
60. Pariante, C. M., Thomas, S. A., Lovestone, S., Makoff, A., & Kerwin, R. W. (2004). Do antidepressants regulate how cortisol affects the brain? Psychoneuroendocrinology, 29, 423-447.
61. Pfohl, B., Blum, N., & Zimmerman, M. (1997). Structured Interview for DSM-IV Personality (SIDP-IV). Washington, DC: American Psychiatric Press.
62. Ritsner, M., Maayan, R., Gibel, A., Strous, R. D., Modai, I., & Weizman, A. (2004). Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. European Neuropsychopharmacology, 14(4), 267-273.
63. Rodenbeck, A., Cohrs, S., Jordan, W., Huether, G., Ruther, E., & Hajak, G. (2003). The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia: a placebocontrolled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology, 170, 423-428.
64. Ryan, M. C., Flanagan, S., Kinsella, U., Keeling, F., & Thakore, J. H. (2004). The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Science, 74, 1999-2008.
65. Ryan, M. C. M., Collins, P., & Thakore, J. H. (2003). Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. American Journal of Psychiatry, 160(2), 284-289.
66. Ryan, M. C. M., Sharifi, N., Condren, R., & Thakore, J. H. (2004). Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology, 29(8), 1065-1070.
67. Saitoh, O., Karns, C. M., & Courchesne, E. (2001). Development of the hippocampal formation from 2 to 42 years: MRI evidence of smaller area dentata in autism. Brain, 124, 1317-1324.
68. Sapolsky, R. M. (1994). Why zebras don't get ulcers. New York: Friedman.
69. Seidman, L. J., Pantelis, C., Keshavan, M. S., Faraone, S. V., Goldstein, J. M., Horton, N. J., Makris, N., Falkai, P., Caviness, V. S., & Tsuang, M. T. (2003). A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: A magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophrenia Bulletin, 29(4), 803-830.
70. Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001). A review of MRI findings in schizophrenia. Schizophrenia Research, 49(1-2), 1-52.
71. Shirayama, Y., Hashimoto, K., Suzuki, Y., & Higuchi, T. (2002). Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophrenia Research, 58(1), 69-74.
72. Sonntag, A., Rothe, B., Guldner, J., Yassouridis, A., Holsboer, F., & Steiger, A. (1996). Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression, 4, 1-13.
73. Sousa, N., & Almeida, O. F. (2002). Corticosteroids: sculptors of the hippocampal formation. Reviews in the Neurosciences, 13(1), 59-84.
74. Spear, L. P. (2000). The adolescent brain and age-related behavioral manifestations. Neuroscience and Biobehavioral Reviews, 24(4), 417-463.
75. Starkman, M. N., Giordani, B., Gebarski, S. S., Berent, S., Schork, M. A., & Schteingart, D. E. (1999). Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biological Psychiatry, 46(12), 1595-1602.
76. Starkman, M. N., Giordani, B., Gebarski, S. S., & Schteingart, D. E. (2003). Improvement in learning associated with increase in hippocampal formation volume. Biological Psychiatry, 53(3), 233-238.
77. Suddath, R. L., Christison, G. W., Torrey, E. F., Casanova, M. F., & Weinberger, D. R. (1990). Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine, 322(12), 789-794.
78. Suzuki, M., Hagino, H., Nohara, S., Zhou, S. Y., Kawasaki, Y., Takahashi., T., Matsui., M., Seto, H., Ono, T., & Kurachi, M. (2005). Male-specific volume expansion of the human hippocampus during adolescence. Cerebral Cortex, 15(2), 187-193.
79. Tessner, K., Walker, E., Dhruv, S., Hamman, S., Hochman K. Post-challenge cortisol levels are inversely associated with hippocampal volume. Unpublished manuscript, 2006.
80. Thakore, J. H., Barnes, C., Joyce, J., Medbak, S., & Dinan, T. G. (1997). Effects of anti-depressant treatment on corticotropin-induced cortisol responses in patients with melancholic depression. Psychiatry Research, 73, 27-32.
81. Tornhage, C. J. (2002). Reference values for morning salivary cortisol concentrations in healthy school-aged children. Journal of Pediatric Endocrinology and Metabolism, 15, 197-204.
82. van der Beek, E. M., Wiegant, V. M., Schouten, W. G., van Eerdenburg, F. J., Loijens, L. W., van der Plas, C., Benning, M. A., de Vries, H., de Kloet, E. R., & Lucassen, P. J. (2004). Neuronal number, volume, and apoptosis of the left dentate gyrus of chronically stressed pigs correlate negatively with basal saliva cortisol levels. Hippocampus, 14(6), 688-700.
83. van Erp, T. G., Saleh, P. A., Huttunen, M., Lonnqvist, J., Kaprio, J., Salonen, O., Valanne, L., Poutanen, V. P., Standertskjold-Nordenstam, C. G., & Cannon, T. D. (2004). Hippocampal volumes in schizophrenic twinsh. Archives of General Psychiatry, 61(4), 346-353.
84. van Haren, N. E., Picchioni, M. M., McDonald, C., Marshall, N., Davis, N., Ribchester, T., Hulshoff Pol, H. E., Sharma, T., Sham, P., Kahn, R. S., & Murray, R. (2004). A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia. Biological Psychiatry, 56(6), 454-461.
85. Wajs-Kuto, E., De Beeck, L. O., Rooman, R. P., & Caju, M. V. (1999). Hormonal changes during the first year of oestrogen treatment in constitutionally tall girls. European Journal of Endocrinology, 141, 579-584.
86. Walder, D. J., Walker, E. F., & Lewine, R. J. (2000). Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia. Biological Psychiatry, 48(12), 1121-1132.
87. Walker, E., & Diforio, D. (1997). Schizophrenia: A neural diathesis-stress model. Psychological Review, 104, 1-19.
88. Walker, E. F. (2002). Adolescent neurodevelopment and psychopathology. Current Directions in Psychological Science, 11(1), 24-28.
89. Walker, E. F., Bonsall, R., & Walder, D. J. (2002). Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry, Neurop-sychology and Behavioral Neurology, 15(1), 10-17.
90. Watzka, M., Beyenburg, S., Blumcke, I., Elger, C. E., Bidlingmaier, F., & Stoeffel-Wagner, B. (2000). Expression of mineralocorticoid and glucocorticoid receptor mRNA in the human hippocampus. Neuroscience Letters, 290(2), 121-124.
91. Weber, A., Clark, A. J., Perry, L. A., Honour, J. W., & Savage, M. O. (1997). Diminished adrenal androgen secretion in familial glucocorticoid deficiency implicates a significant role for ACTH in the induction of adrenarche. Clinical Endocrinology, 46, 431-437.
92. Webster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., & Weickert, C. S. (2002). Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Molecular Psychiatry, 7(9), 985-994.
93. Wik, G. (1995). Effects of neuroleptic treatment on cortisol and 3-methoxy-4 hy-droxyphenylethyl glycol levels in blood. Journal of Endocrinology, 144, 425-429.
94. Wingo, M. K. (2002). The adolescent stress response to a naturalistic driving stressor. Dissertation Abstracts International: Section B: The Sciences & Engineering, 63, 1082.
95. Wolf, O. T., Convit, A., de Leon, M. J., Caraos, C., & Qadri, S. F. (2002). Basal hypothalamo-pituitary-adrenal axis activity and corticotropin feedback in young and older men: Relationships to magnetic resonance imaging-derived hippocampus and cingulate gyrus volumes. Neuroendocrinology, 75(4), 241-249.
96. Zito, J. M., Safer, D. J., Dories, S., Gardner, J. F., Magder, L., Soeken, K., Boles, M., Lynch, F., & Riddle, M. A. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatric and Adolescent Medicine, 157, 17-25.